Personalized MedicineVol. 9, No. 3 General content - EditorialDirect-to-consumer genetic testing: regulating offer or use?Emmanuelle Rial-Sebbag & Pascal BorryEmmanuelle Rial-SebbagUMR U 1027, Inserm, Université de Toulouse, Université Paul Sabatier, Toulouse III, Epidémiologie et analyses en santé publique: risques, maladies chroniques et handicap, Département d’épidémiologie et de santé publique, FranceSearch for more papers by this author & Pascal Borry* Author for correspondenceCentre for Biomedical Ethics & Law, Katholieke Universiteit Leuven, Kapucijnenvoer 35 Box 7001, 3000 Leuven, Belgium. Search for more papers by this authorEmail the corresponding author at Pascal.Borry@med.kuleuven.bePublished Online:4 May 2012https://doi.org/10.2217/pme.12.29AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleKeywords: bioethicsdirect-to-consumerethicalFrancegenetic testinglegalReferences1 Howard HC, Borry P. Is there a doctor in the house?: The presence of physicians in the direct-to-consumer genetic testing context. J. Community Genet.3(2),105–112 (2012).Crossref, Medline, Google Scholar2 Ledley F. A consumer charter for genomic services. Nat. Biotechnol.20(8),767 (2002).Crossref, Medline, CAS, Google Scholar3 Foster MW, Royal CDM, Sharp RR. The routinisation of genomics and genetics: implications for ethical practices. J. Med. Eth.32(11),635–638 (2006).Crossref, Medline, CAS, Google Scholar4 Howard HC, Borry P. Personal genome testing: do you know what you are buying? Am. J. Bioeth.9(6–7),11–13 (2009).Crossref, Medline, Google Scholar5 Janssens AC, Gwinn M, Bradley LA, Oostra BA, van Duijn CM, Khoury MJ. A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions. Am. J. Hum. Genet.82(3),593–599 (2008).Crossref, Medline, CAS, Google Scholar6 Mihaescu R, van HM, Sijbrands EJ et al. Evaluation of risk prediction updates from commercial genome-wide scans. Genet. Med.11(8),588–594 (2009).Crossref, Medline, Google Scholar7 Foster MW, Mulvihill JJ, Sharp RR. Evaluating the utility of personal genomic information. Genet. Med.11(8),570–574 (2009).Crossref, Medline, Google Scholar8 Wade CH, Wilfond BS. Ethical and clinical practice considerations for genetic counselors related to direct-to-consumer marketing of genetic tests. Am. J. Med. Genet. C. Semin. Med. Genet.142(4),284–292 (2006).Crossref, Google Scholar9 Borry P, Howard HC, Senecal K, Avard D. Health-related direct-to-consumer genetic testing: a review of companies’ policies with regard to genetic testing in minors. Fam. Cancer9(1),51–59 (2010).Crossref, Medline, Google Scholar10 McGuire A, Diaz CM, Wang T, Hilsenbeck S. Social networkers’ attitudes toward direct-to-consumer personal genome testing. Am. J. Bioeth.9(6–7),3–10 (2009).Crossref, Medline, Google Scholar11 Borry P, van Hellemondt RE, Sprumont D et al. Legislation on direct-to-consumer genetic testing in seven European countries. Eur. J. Hum. Genet. doi:10.1038/ejhg.2011.278 (2012) (Epub ahead of print).Google Scholar12 Law 94-653 of 29 July 1994 on respect for the human body (1994) (French Law).Google Scholar13 Law 94-654 of 29 July 1994 on the gift and use of parts and products of the human body, for medical assistance to procreation and prenatal diagnosis (1994) (French Law).Google Scholar14 Law 2011-814 of 7 July 2011 on Bioethics (2011) (French Law).Google ScholarFiguresReferencesRelatedDetailsCited ByPersonalizing health care: feasibility and future implications13 August 2013 | BMC Medicine, Vol. 11, No. 1“It’s our DNA, we deserve the right to test!” A content analysis of a petition for the right to access direct-to-consumer genetic testingYeyang Su, Pascal Borry, Ina C Otte & Heidi C Howard10 September 2013 | Personalized Medicine, Vol. 10, No. 7Survey of European clinical geneticists on awareness, experiences and attitudes towards direct-to-consumer genetic testingGenome Medicine, Vol. 5, No. 5To ban or not to ban?14 August 2012 | EMBO reports, Vol. 13, No. 9 Vol. 9, No. 3 Follow us on social media for the latest updates Metrics Downloaded 210 times History Published online 4 May 2012 Published in print May 2012 Information© Future Medicine LtdKeywordsbioethicsdirect-to-consumerethicalFrancegenetic testinglegalAcknowledgementsThe authors would like to thanks HC Howard for comments on a draft of the manuscript.Financial & competing interests disclosureE Rial-Sebbag is supported by the TEGALSI contract Institut de recherche en santé publique (Services de santé – politiques publiques et santé 2009). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.No writing assistance was utilized in the production of this manuscript.PDF download
Read full abstract